With that becoming said, with out human trials there is not any way to actually evaluate the amount of YK11 can inhibit Myostatin in individuals (if at all), and when there is a dosage that might equate to a similar standard of Myostatin inhibition that a genetic anomaly having a gene mutation has.This analyze doesn’t aid us A lot in identifying